ESR1 and breast carcinoma: In NCT03083288, 30 breast cancer patients (stage I to IV) with a range of breast cancer phenotypes (estrogen receptor-positive, human epidermal growth factor receptor-positive or triple negative) were enrolled and the BRCA status was analyzed.